---
title: 'Director/Senior Director, QMS, Digital QA and GxP Compliance at Crescent Biopharma'
canonical: 'https://feeny.ai/job/director-senior-director-qms-digital-qa-and-gxp-compliance-crescent-biopharma-brmrgq5qf5xc'
type: 'job'
last_seen: '2026-09-10'
---

# Director/Senior Director, QMS, Digital QA and GxP Compliance at Crescent Biopharma

- **Company:** Crescent Biopharma
- **Location:** Waltham, MA
- **Employment:** full-time
- **Work type:** onsite
- **Posted:** 2026-07-28
- **Last confirmed live:** 2026-09-10
- **Apply:** https://jobs.lever.co/crescent-biopharma/70732274-f1db-49f7-9ef2-e7c7216ebee1

## Job description

Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies as single agents and as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X. We are seeking a Director/Senior Director, Quality Management Systems (QMS), Digital Quality Assurance and GxP Compliance to be a key leader within Crescent’s Quality organization, responsible for the design, implementation, and oversight of the Company’s Quality Management System (QMS), GxP digital quality platforms, GxP vendor management program, and inspection readiness activities. You will provide strategic and hands-on leadership to ensure quality systems and computerized/digital systems are fit for intended use, compliant with global regulatory requirements, and scalable to support Crescent’s clinical-stage development programs. You will partner closely with cross-functional stakeholders, IT, and external vendors to ensure appropriate validation, data integrity, vendor qualification and oversight, inspection readiness, and continuous improvement within a highly outsourced operating model.

## Responsibilities

- Provide leadership and oversight for Crescent’s Quality Management System, including document management, training, quality events, and associated digital platforms.
- Serve as the Quality Business Owner (or designee) for Quality Systems, including implementation, validation oversight, periodic review, and lifecycle management.
- Ensure QMS and GxP digital systems remain in a validated state through appropriate validation strategies, risk-based approaches, and change control governance.
- Lead continuous improvement initiatives across quality systems and processes, identifying opportunities to enhance usability, compliance, and efficiency.
- Provide QA oversight of GxP computerized systems, including validation strategy, periodic reviews, user access reviews, system inventories, and inspection readiness.
- Lead and oversee Change Control activities related to quality systems and digital platforms.
- Develop, track, and report Quality System metrics and trends to Quality Management and senior leadership.
- Ensure effective document control and GxP training management across all functions, supporting consistent adoption of Crescent’s Quality System.
- Partner with functional teams to support the development, implementation, and maintenance of policies, SOPs, work instructions, and related quality documentation.
- Lead the development and execution of GxP training strategies, including onboarding, role-based training, and annual refresher programs.
- Provide oversight of quality system deviations, investigations, and CAPAs, ensuring timely root cause analysis and effective remediation.
- Support Quality governance forums (e.g., Quality Review Boards), presenting system performance, compliance trends, and risk assessments.
- Provide QA oversight of vendors and service providers supporting QMS and GxP computerized systems, including qualification, audits, quality agreements, and performance monitoring.
- Own and lead Crescent’s GxP vendor management program, including coordination of all vendor qualification activities and management of the master audit schedule for GxP vendors and service providers.
- Ensure Quality Agreements are established, executed, and maintained with GxP vendors where required, partnering with Legal and Procurement as needed.
- Drive vendor audit CAPAs through to full closure, ensuring timely follow-up, escalation of overdue actions, and verification of effectiveness.
- Maintain and continuously update the Approved Vendor List (AVL), ensuring accuracy and alignment with current vendor qualification status.
- Serve as the lead for Inspection Readiness across the Quality organization, ensuring a continuous state of inspection readiness, coordinating mock inspections and readiness assessments, and helping the organization prepare for regulatory inspections or business partner audits and response.
- Support internal audits and regulatory inspections related to quality systems and digital quality platforms, including inspection preparation and follow-up.
- Ensure alignment of Quality Systems with evolving regulatory expectations, industry best practices, and Crescent’s stage of development.
- Contribute to departmental planning, including budgeting for systems, vendors, and resources.
- Mentor QA staff and external consultants and foster a strong quality culture grounded in accountability, collaboration, and continuous improvement.
- Stay current on global regulations, industry trends, and best practices related to Quality Systems and digital quality, driving continuous improvement within the QA function.

Education & Experience

- Bachelor’s degree in a scientific, technical, quality, or related discipline; advanced degree preferred.
- 8-10 years of progressive experience in Quality Systems and Digital Quality Assurance within biotech or pharmaceutical development.
- Demonstrated expertise in Quality Management Systems, GxP computerized systems, and data integrity principles.
- Strong working knowledge of global regulatory requirements and guidance, including FDA, EU regulations, ICH guidelines, GAMP, and phase-appropriate application.
- Proven experience leading system implementations, validation strategies, and continuous improvement initiatives.
- Experience providing QA oversight of vendors and outsourced services, including GxP vendor qualification, audit programs, quality agreements, and CAPA management.
- Experience leading Inspection Readiness programs, including preparing organizations for regulatory inspections and driving cross-functional readiness activities.
- Demonstrated experience supporting regulatory inspections and internal audits related to quality systems and computerized systems.
- Strategic, hands-on leader with the ability to balance long-term system strategy with day-to-day operational execution.
- Strong collaboration, communication, and influencing skills, with the ability to lead cross-functional teams.
- Ability to thrive in a fast-paced, evolving environment with changing priorities.
- Commitment to fostering a culture of quality, integrity, inclusion, and continuous improvement.

## What We Offer

- Opportunity to join a mission-driven team where you'll contribute to impactful work, take on varied responsibilities, and grow quickly in a dynamic environment
- Competitive compensation, including base salary, performance bonus, and equity
- 100% employer-paid benefits package
- Flexible PTO; also, two, one-week company-wide shutdowns each year
- A commitment to your professional development, with access to resources, mentorship, and growth opportunities

Salary Range

The salary range for this position is $200,000 to $260,000. The final salary offered will depend on several factors, which may include, but is not limited to relevant years of experience, educational background, and geography.

Additional Description for Pay Transparency:

The final salary offered will depend on several factors, which may include, but is not limited to relevant years of experience, educational background, and geography. Subject to the terms of their respective plans, employees and/or eligible dependents are eligible to participate in the following Company sponsored employee benefit programs: medical, dental, vision, life insurance, short- and long-term disability. Subject to the terms of their respective plans, employees are eligible to participate in the Company’s savings plan (401(k)). This position is eligible to participate in the Company’s long-term incentive program. Subject to the terms of their respective policies and date of hire, Employees are eligible for the following time off benefits: Vacation – Unlimited PTO; Sick time – 10 days per calendar year; Holiday pay, including two Company shut downs; Parental Leave – 16 weeks within one year of the birth/adoption/foster care of a child; FMLA; Military Leave. Additional information can be found - [https://www.crescentbiopharma.com/careers/#benefits](https://nam13.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.crescentbiopharma.com%2Fcareers%2F%23benefits&data=05%7C02%7Clee.schwartz%40crescentbiopharma.com%7Ca470e7b902eb4129a1a808de166a540b%7Cea3ae1e37f5f46159580d5c6e0711b3c%7C0%7C0%7C638972843088266995%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=wT1Z9wts792%2FEuLYQJs2HxHxehSvTRx7cAguiMD4XY0%3D&reserved=0)

Please note: Crescent Biopharma is an Equal Opportunity Employer. We are committed to fostering a diverse, inclusive, and equitable workplace where all individuals are valued and respected. Employment decisions are based on qualifications, merit, and business needs, without regard to race, color, religion, gender, sexual orientation, national origin, disability, veteran status, or any other protected status. Please note, Crescent does not accept unsolicited resumes from external agencies or recruiters. Submission of a resume without a prior written agreement does not create any express or implied contract between Crescent and the agency. Crescent will not pay any fees related to unsolicited resumes.

## #LI-CBIO

## About Crescent Biopharma

## Company Overview
- **One-liner**: Crescent Biopharma is a clinical-stage oncology company developing next-wave cancer therapies, including a PD-1 x VEGF bispecific antibody and antibody-drug conjugates (ADCs) for solid tumors.
- **Entity Type**: Public (IPO in June 2025; ticker not disclosed in available data)
- **Headquarters**: Waltham, Massachusetts, United States (300 Fifth Avenue, Waltham, MA 02451)
- **Founded**: Year not publicly available (company appears to have been active before 2024; IPO in 2025)
- **Founders**: Not publicly available (leadership includes CEO Joshua Brumm, but founder information is not listed)

## Core Business
- **Primary industry/industries**: Oncology biotechnology / Therapeutics
- **Target customers**: B2B – primarily focuses on developing and commercializing cancer therapies, with partnerships and collaborations (e.g., Kelun-Biotech, Paragon Therapeutics)
- **Mission or purpose statement**: “Delivering the next wave of transformative therapies to bring a brighter future for people living with cancer.”

## Products & Services
- **CR-001 (PD-1 x VEGF bispecific antibody)**: A tetravalent bispecific antibody in Phase 1/2 clinical trials (ASCEND) for advanced solid tumors. Designed to exhibit cooperative pharmacology similar to ivonescimab; aims to restore T-cell activity and localize anti-VEGF activity in the tumor microenvironment. Collaboration with Kelun-Biotech for Greater China rights.
- **CR-002 (PD-L1–directed ADC)**: A topoisomerase inhibitor ADC targeting PD-L1, with high internalization. IND planned for mid-2026, with Phase 1/2 trial expected in H2 2026.
- **CR-003 (ITGB6–directed ADC)**: A differentiated ADC targeting integrin beta-6 (ITGB6), with a topoisomerase 1 inhibitor payload. Uses Kthiol conjugation technology. Licensed from Kelun-Biotech for ex-Greater China markets; Phase 1/2 trial ongoing in China.

## Market Standing
- **Valuation/Market Cap**: Not disclosed (public company as of 2025, but no valuation or market cap figure available in provided data)
- **Key Metric**: Total Funding: $585M (including $200M Series A in 2024, $185M Post-IPO Equity in 2025, and $200M Post-IPO Equity in 2025 led by Fairmount Funds Management)
- **Notable Investors/Partners**: Fairmount Funds Management, Venrock Healthcare Capital Partners, Kelun-Biotech (strategic collaboration), Paragon Therapeutics
- **Growth Signals**: Headcount grew 129.6% YoY to 55 employees (LinkedIn); IPO in June 2025; multiple pipeline programs advancing toward IND; expansion into ADC combination trials

## Competitive Advantages
- Focus on established, clinically validated targets (PD-1, VEGF, PD-L1, ITGB6) to reduce risk and accelerate development
- Multi-modality approach (bispecific antibodies + ADCs) enabling combination therapies with potential synergistic effects
- Proprietary ADC technology (Kthiol conjugation) and strategic collaborations for global rights to differentiated assets
- Strong leadership team with deep oncology drug development expertise (former executives from major biopharma)

## Strategic Focus
- Advance CR-001 as a foundational backbone therapy, with initiation of combination trials with ADCs in H2 2026
- Submit IND for CR-002 in mid-2026 and begin Phase 1/2 trials
- Progress CR-003 clinical program and explore additional internal and partnered ADC and immuno-oncology opportunities
- Build a leading oncology company through disciplined execution, leveraging established biology and multiple modalities

## Why Work Here
- **Culture highlights**: “No egos, collaborative spirit,” “roll up sleeves,” “move with urgency,” “data-driven science with patients as true north.” Emphasizes transparency, integrity, and impact.
- **Remote/hybrid/office policy**: Not explicitly stated; headquarters in Waltham, MA, with an office in Rockville, MD. Likely requires on-site presence given the “highly collaborative” and “urgent” culture.
- **Notable perks**: 100% employer-paid medical, dental, vision, short/long-term disability, life insurance; HSA and dependent care FSA; 401(k); subsidized lunch program; flexible vacation and paid holidays including summer and year-end office closures (one week each).
- **Best for**: Bold innovators who want to make a significant impact in oncology drug development, thrive in a fast-paced, transparent environment, and are motivated by patient outcomes.

## Sources
1. [crescentbiopharma.com – Careers](https://www.crescentbiopharma.com/careers/)
2. [crescentbiopharma.com – About](https://www.crescentbiopharma.com/about/)
3. [crescentbiopharma.com – Pipeline](https://www.crescentbiopharma.com/pipeline/)
4. [linkedin.com – Crescent Biopharma](https://www.linkedin.com/company/crescent-biopharma)
5. [jobs.lever.co – Crescent Biopharma](https://jobs.lever.co/crescent-biopharma)

## Other roles at Crescent Biopharma

- [Executive Director/Vice President, Corporate Development](https://feeny.ai/job/executive-director-vice-president-corporate-development-crescent-biopharma-a167et02k0jt) — Waltham, MA
- [Director, Clinical Supply Chain](https://feeny.ai/job/director-clinical-supply-chain-crescent-biopharma-waltham-92w8s0ryzk1d) — Waltham, MA
- [Associate Director/Director, Bioanalysis](https://feeny.ai/job/associate-director-director-bioanalysis-crescent-biopharma-waltham-wfq3aj03vtzf) — Waltham, MA
- [Director, ADC Drug Substance](https://feeny.ai/job/director-adc-drug-substance-crescent-biopharma-waltham-7dyxva49nmt1) — Waltham, MA
- [Director/Senior Director, Drug Product](https://feeny.ai/job/director-senior-director-drug-product-crescent-biopharma-waltham-pj5x6ve5sp22) — Waltham, MA
- [Executive Assistant - R&D](https://feeny.ai/job/executive-assistant-r-d-crescent-biopharma-waltham-th1vr004bn6z) — Waltham, MA
- [Senior Director, Global Medical Affairs](https://feeny.ai/job/senior-director-global-medical-affairs-crescent-biopharma-waltham-hz7hjwnnayha) — Waltham, MA
- [Clinical Trial Associate/Senior Clinical Trial Associate](https://feeny.ai/job/clinical-trial-associate-senior-clinical-trial-associate-crescent-biopharma-9tepp4hjn5fr) — Waltham, MA
- [Director/Senior Director, GMP Quality Assurance Operations](https://feeny.ai/job/director-senior-director-gmp-quality-assurance-operations-crescent-biopharma-zt813qk13fnp) — Waltham, MA
- [Manager, CMC Project Management](https://feeny.ai/job/manager-cmc-project-management-crescent-biopharma-waltham-bad0nec61tqz) — Waltham, MA